Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy

被引:48
作者
Khaleeli, A. A.
Johnson, J. N.
Taylor, W. H.
机构
[1] Halton Gen Hosp, Dept Med, Runcorn WA7 2DA, Cheshire, England
[2] Halton Gen Hosp, Dept Surg, Runcorn WA7 2DA, Cheshire, England
关键词
diabetes mellitus; primary hyperparathyroidism; parathyroidectomy; glucose intolerance and oral glucose tolerance test;
D O I
10.1002/dmrr.637
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Increased prevalence of diabetes mellitus (DM) in primary hyperparathyroidism (PHPT) is established, but not glucose intolerance (GI), nor benefit from parathyroidectomy on GI. We determined these during management of a continuous series of patients with PHPT routinely followed after surgery. Patients and methods WHO criteria classified 75 g oral glucose tolerance tests (OGTT) in 51/54 consecutively proven PHPT patients, into normal glucose tolerance (NGT), DM, impaired glucose tolerance (IGT) or impaired fasting glucose (IFG); GI was derived by adding those with DM and IGT/IFG. OGTT were repeated after parathyroidectomy (mean follow up 2.4 +/- SD 1.6 years). Paired student t tests were used to compare fasting and 2-h plasma glucose (PG). Results At presentation 32/54 patients (59%) had NGT, 10 IGT/IFG (19%) and 12 type 2 DM (22%), nine newly diagnosed. Before parathyroidectomy 17/35 patients had NGT (49%), 18 GI (51%), 12 DM (34%) and 6 IGT/IFG (17%). Five out of six patients with IGT/IFG had NGT, one with NGT developed IGT. At completion 23 patients (66%) had NGT, 12 GI (34%), 4 IGT/IFG (11%) and 8 DM (23%). After parathyroidectomy fasting and 2-h. PG fell in 30/34 normocalcaemic patients not on hypoglycaemic agents, 5.6 +/- 1.0 to 5.4 +/- 0.8 mmol/l, 7.2 +/- 3.0 to 6.3 +/- 3.1 mmol/l (p < 0.05, p < 0.01). Conclusions 1. At presentation with PHPT, OGTT commonly identifies Type 2 DM and GI. 2. After successful parathyroidectomy fasting and 2-h. PG fall significantly (p < 0.05, p < 0.01). DM and IGT/IFG often ameliorates to IGT or NGT, persistently. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 31 条
[1]   HYPER-PARATHYROIDISM AND COEXISTING DIABETES-MELLITUS - ALTERED CARBOHYDRATE-METABOLISM [J].
AKGUN, S ;
ERTEL, NH .
ARCHIVES OF INTERNAL MEDICINE, 1978, 138 (10) :1500-1502
[2]  
[Anonymous], 1999, WHONCDNCS992 1
[3]  
BALLIN M, 1931, AM J SURG, V12, P403
[4]   THE RELATIONSHIP BETWEEN PRIMARY HYPERPARATHYROIDISM AND DIABETES-MELLITUS [J].
BANNON, MP ;
VANHEERDEN, JA ;
PALUMBO, PJ ;
ILSTRUP, DM .
ANNALS OF SURGERY, 1988, 207 (04) :430-433
[5]  
CHEUNG PSY, 1986, SURGERY, V100, P1039
[6]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[7]  
GINSBERG H, 1975, P SOC EXP BIOL MED, V148, P942
[8]  
HELLSTROM J, 1962, ACTA CHIR SCAND S, V294, P7
[9]   Complete histological regression of metastatic carcinoid tumour after treatment with octreotide [J].
Imtiaz, KE ;
Monteith, P ;
Khaleeli, A .
CLINICAL ENDOCRINOLOGY, 2000, 53 (06) :755-758
[10]  
KEATING FR, 1969, J LAB CLIN MED, V74, P507